Chinese Regulatory Authority [NMPA] Approves IND Application of Oramed’s Oral Insulin Capsules

NEW YORK: Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) (TASE: ORMP) (www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, announced today that its Chinese
error: Content is protected !!